Authors: HARBARTH S PITTET D GABRIEL V GARBINO J LEW D

Citation: S. Harbarth et al., CEFEPIME - ASSESSMENT OF ITS NEED AT A TERTIARY CARE CENTER, Journal of clinical pharmacy and therapeutics, 23(1), 1998, pp. 11-17

Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P

Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624

Authors: VANHEMS P MORABIA A PECHERE M GABRIEL V HIRSCHEL B

Citation: P. Vanhems et al., DURATION OF HOSPITALIZATION DURING THE FIRST 2 YEARS AFTER AIDS DIAGNOSIS - A DESCRIPTIVE STUDY, Sozial- und Praventivmedizin, 42(5), 1997, pp. 314-319

Authors: VANDELDEN C GABRIEL V SUDRE P FLEPP M VONOVERBECK J HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P

Citation: C. Vandelden et al., REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS, AIDS, 10(5), 1996, pp. 509-513

Authors: PECHERE M OPRAVIL M WALD A CHAVE JP BESSESEN M SIEVERS A HEIN R VONOVERBECH J CLARK RA TORTOLI E EMLER S KIRSCHNER P GABRIEL V BOTTGER EC HIRSCHEL B

Citation: M. Pechere et al., CLINICAL AND EPIDEMIOLOGIC FEATURES OF INFECTION WITH MYCOBACTERIUM GENAVENSE, Archives of internal medicine, 155(4), 1995, pp. 400-404

Authors: GABRIEL V PACKHAM DR

Citation: V. Gabriel et Dr. Packham, HETEROSEXUAL TRANSMISSION - A GROWING RISK FACTOR FOR HIV SPREAD, Australian and New Zealand Journal of Obstetrics and Gynaecology, 33(2), 1993, pp. 174-176